Author Robert E. Way takes listeners behind the scenes of his upcoming book, The Cheapest Drug on Earth: Inside the World of Repurposed Medicines and the Fight Against Cancer and Parasites, on his own podcast, CounterCast.
This special episode isn’t just a book promotion—it’s the candid story of why Robert wrote the book in the first place. Driven by his own questions and experiences, Robert dives into ivermectin, repurposed medicines, cancer research, pharmaceutical economics, and the critical distinction between a promising laboratory finding and a proven human treatment.
Exploring the Nuance of Repurposed Medicine
In the episode, Robert addresses the uncomfortable economic and scientific questions surrounding modern medicine:
- The Financial Gap: What happens when an inexpensive drug shows scientific promise but lacks the financial incentive required to fund expensive clinical trials?
- Balanced Skepticism: Why cheap doesn’t automatically mean effective, controversial doesn’t automatically mean suppressed, and skepticism toward big pharma shouldn’t lead to blind faith in alternative claims.
- The Catch-22: How potentially useful treatments can be overlooked while other claims are wildly overstated—and how both realities can exist simultaneously.
“If this episode makes you curious, skeptical, irritated, interested, or sends you down your own research rabbit hole, good. That’s the point.” — Robert E. Way
Watch, Listen & Read
- Watch the Video: Watch the Full CounterCast Episode on YouTube
- Subscribe: Tune in to CounterCast for conversations that challenge comfortable answers and question standard premises.
- Get the Book: The Cheapest Drug on Earth by Robert E. Way is heading soon to major online retailers and booksellers.
